跳至主要内容
临床试验/DRKS00025495
DRKS00025495已完成未知

Measurement of the glycaemic index (GI) of enteral nutrition formulations in healthy subjects - GCOS-008-CE

Fresenius Kabi Deutschland GmbH0 个研究点目标入组 12 人开始时间: 2021年6月17日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
12

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomized controlled study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 60 Years(—)
性别
All

入选标准

  • Healthy subjects who give informed consent to participate in the study and fulfill the eligibility criteria according to ISO 26642

排除标准

  • 1. Aged < 18 or > 60 years; 2. Pregnant or lactating; 3. Body mass index (BMI) > 30kg/m2; 4. Known history of diabetes mellitus or fasting blood glucose value > 6.1 mmol/l or the use of anti-hyperglycaemic drugs or insulin; 5. Any known food allergy or intolerance;6. Medical condition(s) or medication(s) known to affect glucose regulation, tolerance or appetite and/or which influence digestion and absorption of nutrients (excluding oral contraceptives); 7. Hospitalization within the preceding 3 months; 8. Use of steroids, protease inhibitors, amphetamines or antipsychotics; 9. Participants who are unable to comply with experimental procedures or do not follow GI testing safety guidelines.

研究者

相似试验